22.23
전일 마감가:
$22.58
열려 있는:
$22.6
하루 거래량:
408.76K
Relative Volume:
0.73
시가총액:
$1.06B
수익:
$151.91M
순이익/손실:
$-46.03M
주가수익비율:
-22.01
EPS:
-1.01
순현금흐름:
$5.65M
1주 성능:
+7.08%
1개월 성능:
+3.44%
6개월 성능:
-21.97%
1년 성능:
-7.53%
바이오라이프 솔루션즈 Stock (BLFS) Company Profile
명칭
Biolife Solutions Inc
전화
(425) 401-1400
주소
3303 MONTE VILLA PARKWAY, BOTHELL, WA
BLFS을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
BLFS
Biolife Solutions Inc
|
22.23 | 1.08B | 151.91M | -46.03M | 5.65M | -1.01 |
![]()
ISRG
Intuitive Surgical Inc
|
493.95 | 177.75B | 9.15B | 2.61B | 1.99B | 7.17 |
![]()
BDX
Becton Dickinson Co
|
182.94 | 53.11B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ALC
Alcon Inc
|
90.15 | 45.44B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
273.50 | 40.35B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
WST
West Pharmaceutical Services Inc
|
257.76 | 18.95B | 2.90B | 467.20M | 306.90M | 6.37 |
바이오라이프 솔루션즈 Stock (BLFS) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-07-22 | 재개 | Stephens | Overweight |
2024-09-30 | 개시 | H.C. Wainwright | Buy |
2024-04-04 | 개시 | Jefferies | Buy |
2023-07-11 | 개시 | Craig Hallum | Buy |
2022-04-25 | 업그레이드 | Oppenheimer | Perform → Outperform |
2021-10-19 | 개시 | B. Riley Securities | Buy |
2021-10-15 | 재개 | Cowen | Outperform |
2021-05-14 | 다운그레이드 | The Benchmark Company | Buy → Hold |
2021-03-23 | 업그레이드 | The Benchmark Company | Hold → Buy |
2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
2020-09-22 | 다운그레이드 | Oppenheimer | Outperform → Perform |
2020-09-18 | 개시 | Cowen | Outperform |
2020-08-11 | 다운그레이드 | The Benchmark Company | Buy → Hold |
2020-07-08 | 재확인 | Maxim Group | Buy |
2020-02-24 | 개시 | Lake Street | Buy |
2020-02-19 | 개시 | The Benchmark Company | Buy |
2020-02-06 | 재개 | B. Riley FBR | Buy |
2020-01-08 | 개시 | Stephens | Overweight |
2019-11-21 | 개시 | Oppenheimer | Outperform |
2019-07-22 | 개시 | H.C. Wainwright | Buy |
2017-11-10 | 재확인 | Maxim Group | Buy |
2017-09-19 | 재확인 | Maxim Group | Buy |
2017-07-05 | 업그레이드 | Janney | Neutral → Buy |
2017-03-10 | 재확인 | Maxim Group | Buy |
2017-01-19 | 개시 | Maxim Group | Buy |
모두보기
바이오라이프 솔루션즈 주식(BLFS)의 최신 뉴스
Pluristyx, Inc. announced that it has received $2 million in funding from BioLife Solutions, Inc. - MarketScreener
Why is BioLife Solutions Inc. stock attracting strong analyst attentionCapitalize on fast-growing stocks today - jammulinksnews.com
BioLife Solutions Makes $2 Million Investment in Pluristyx - MarketScreener
BioLife Solutions invests $2 million in stem cell developer Pluristyx By Investing.com - Investing.com India
Biolife Solutions makes strategic investment in Pluristyx - MarketScreener
BioLife Solutions Expands Cell Therapy Portfolio Through Strategic $2M Investment in Pluristyx iPSC Technology - Stock Titan
How BioLife Solutions Inc. stock performs during market volatilityFree Weekly Setup With 3x Return Potential - Newser
Is BioLife Solutions Inc. a Top Dividend Stock to Watch in 2025Momentum Entry Alerts with Risk Control - Newser
Reversal indicators forming on BioLife Solutions Inc. stockFree Fast Return Equity Trade Forecast - Newser
Is this a good reentry point in BioLife Solutions Inc.Portfolio Allocation Strategy for Stability - Newser
What makes BioLife Solutions Inc. stock price move sharplyTechnical Confirmation System with Signal Alerts - Newser
New Product Launches: Will They Boost BioLife Solutions Inc. Stock in 2025Trend Following Trades - metal.it
Is BioLife Solutions Inc. a growth stock or a value stockBuild a winning investment strategy - jammulinksnews.com
What is BioLife Solutions Inc. company’s growth strategyUnlock daily market insights for better trades - jammulinksnews.com
When is BioLife Solutions Inc. stock expected to show significant growthMaximize returns with strategic stock selection - jammulinksnews.com
BioLife Solutions Inc. Company Revenue and Profit Trends: A Deep DiveFree Elite Traders Group - Newser
How Resilient Is BioLife Solutions Inc. Stock During Economic DownturnsStrong Buy Recommendations - Newser
BioLife Solutions Inc. Stock Analysis and ForecastOutstanding risk-reward balance - PrintWeekIndia
Is BioLife Solutions Inc. a good long term investmentFree Consultation - PrintWeekIndia
What analysts say about BioLife Solutions Inc. stockRapid wealth accumulation - Autocar Professional
Bank of New York Mellon Corp Has $5.07 Million Stock Position in BioLife Solutions, Inc. (NASDAQ:BLFS) - Defense World
(BLFS) Investment Analysis - news.stocktradersdaily.com
When is the best time to buy BioLife Solutions Inc. stockBreakthrough wealth creation - jammulinksnews.com
BioLife Solutions to Report Second Quarter 2025 Financial Result - GuruFocus
BioLife Solutions to Report Second Quarter 2025 Financial Results and Business Update on August 7, 2025 - MarketScreener
Cell Therapy Leader BioLife Solutions Announces Q2 2025 Earnings Date: Key Bioproduction Updates Expected - Stock Titan
What risks could impact BioLife Solutions Inc. stock performanceOver 200% growth - jammulinksnews.com
Envestnet Asset Management Inc. Has $6.24 Million Stock Position in BioLife Solutions, Inc. (NASDAQ:BLFS) - Defense World
BioLife Solutions, Inc. (NASDAQ:BLFS) Shares Bought by Cerity Partners LLC - Defense World
Cerity Partners LLC Buys 9,015 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS) - Defense World
What drives BioLife Solutions Inc. stock priceHigh-impact stock picks - jammulinksnews.com
BioLife Solutions (BLFS) Receives Overweight Rating with Bullish Outlook | BLFS Stock News - GuruFocus
BioLife Solutions resumed with an Overweight at Stephens - TipRanks
Tissue Banking Market Is Booming So Rapidly 2025-2032 -BioLife - openPR.com
New York State Common Retirement Fund Purchases 37,133 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS) - Defense World
BioLife Solutions, Inc. (NASDAQ:BLFS) Shares Purchased by Principal Financial Group Inc. - Defense World
바이오라이프 솔루션즈 (BLFS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):